ReviewAnnals of biomedical engineering2026
Screening and Evaluation of Post-stroke Dysphagia: Insights from Neurology, Artificial Intelligence and Data Science-A Scoping Review.
Review in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-stroke dysphagia (PSD) affects approximately 42% of acute stroke patients, increasing hospitalization costs and length of stay. Early identification improves outcomes, yet many patients-especially in low-resource settings-lack access to gold-standard evaluations. This scoping review explores the integration of artificial intelligence (AI) and data science-defined as the interdisciplinary use of computational methods, statistical modeling, and machine learning to extract clinically meaningful patterns from biomedical data-in PSD screening and assessment. We synthesize evidence from bedside screening instruments, acoustic voice analyses, and emerging AI-driven models for dysphagia and aspiration risk stratification, critically appraising limitations related to small datasets, overfitting risk, and the need for external validation. Traditional tools like the water swallow test show high sensitivity but varying specificity; recent studies support augmenting these with voice-based biomarkers such as post-swallow wet voice, jitter, and shimmer. While wet voice as a standalone marker has limited sensitivity (8-29%), its high specificity (75-94%) within multimodal approaches justifies continued investigation. AI models trained on acoustic parameters have demonstrated strong performance in detecting penetration-aspiration events, while mobile and voice-based platforms may expand diagnostic reach, pending further validation. We also review optimal screening timing, emphasizing assessment within 24 h of stroke onset with repeated evaluations for high-risk patients. Future directions advocate multimodal, patient-centered approaches combining wearable biosensors, cloud-based analytics, and culturally adapted algorithms, while addressing implementation challenges including infrastructure requirements, digital literacy, workflow integration, and ethical considerations. The convergence of clinical expertise and computational technologies presents a promising path to equitable, scalable, and precise dysphagia care.
Indexed as
Identifiers
42384315What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.